Brookfield Corporation
BAM
$49.57
+1.12%
Brookfield Asset Management is one of the world's largest alternative-asset managers, with $1.181 trillion in total managed assets, operating across credit, private equity, and real assets. The firm is a market leader in alternative investments, distinguished by its scale, global diversification, and strong institutional client base (90% of AUM). The current investor narrative centers on the company's ability to sustain fee-earning AUM growth amid market volatility, with recent news highlighting strategic acquisitions and partnerships that underscore its capital deployment prowess.…
BAM
Brookfield Corporation
$49.57
Related headlines
Investment Opinion: Should I buy BAM Today?
Rating: Hold. BAM is a high-quality asset manager with strong growth and margins, but its premium valuation and persistent downtrend warrant caution. The analyst consensus is Buy with an average target of $56.58, implying 15.4% upside, but the stock's technical weakness and high payout ratio suggest limited near-term catalysts.
Supporting Evidence: Revenue growth of 22.1% YoY in Q1 2026 outpaces the industry average of ~8%. Net margin of 46.1% is more than double the industry average of ~20%. The forward PE of 22.5x implies expected earnings growth of ~51%, which is aggressive but supported by the company's trajectory. Free cash flow of $2,315 million TTM provides a cushion, and the ROE of 27.9% indicates efficient capital use. However, the trailing PE of 34.0x is a 70% premium to the industry, and the stock has underperformed the S&P 500 by 34.5% over the past year.
Risks & Conditions: The Hold rating would upgrade to Buy if the stock pulls back to the $42-44 range (near the 52-week low) or if revenue growth accelerates above 25%. It would downgrade to Sell if AUM growth decelerates below 10% or if the payout ratio remains above 100% for two consecutive quarters. Overall, BAM is fairly valued relative to its growth but overvalued relative to its industry peers on a trailing basis.
Sign up to view all
BAM 12-Month Price Forecast
BAM's fundamentals are strong, with accelerating revenue growth and best-in-class margins. However, the stock's premium valuation and persistent underperformance relative to the market create a balanced risk/reward. The base case of 15.4% upside to the average target is achievable if growth continues, but the bear case of 14% downside to the 52-week low is equally plausible if sentiment weakens. The neutral stance reflects the tension between quality and price. An upgrade to bullish would require a pullback to a more attractive valuation or a clear catalyst for multiple expansion.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brookfield Corporation's 12-month outlook, with a consensus price target around $56.58 and implied upside of +14.1% versus the current price.
Average Target
$56.58
0 analysts
Implied Upside
+14.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$44 - $69
Analyst target range
BAM is covered by 18 analysts, with a consensus recommendation of 'Buy' (mean rating 2.28 on a 1-5 scale, where 1 is Strong Buy). The average target price is $56.58, implying 15.4% upside from the current price of $49.02. The distribution shows 10 Buy, 5 Hold, and 3 Sell ratings, indicating a generally bullish but cautious sentiment. The target price range spans from a low of $44.00 to a high of $69.00, representing a wide spread of $25.00. The low target of $44.00 implies a 10.2% downside from current levels, potentially pricing in margin compression or slower AUM growth. The high target of $69.00 assumes continued strong performance and multiple expansion. Recent ratings actions show no changes since May 2026, with firms like Piper Sandler (Neutral), Scotiabank (Sector Outperform), and RBC Capital (Outperform) maintaining their stances. The wide target spread reflects high uncertainty around the pace of AUM growth and fee income, but the consensus leans bullish.
Bulls vs Bears: BAM Investment Factors
BAM presents a classic growth-at-a-reasonable-price debate. The bull case is anchored by 22% revenue growth, industry-leading margins, and a strong balance sheet, supported by a consensus Buy rating with 15.4% upside. The bear case centers on a premium valuation (34x trailing PE vs. 20x industry) and a persistent downtrend that has underperformed the S&P 500 by 34.5% over the past year. The single most important tension is whether BAM can sustain its fee-earning AUM growth trajectory to justify its premium multiple. If growth decelerates, the stock could re-rate lower; if it accelerates, the current price could prove a bargain.
Bullish
- Strong Revenue Growth: Revenue grew 22.1% YoY in Q1 2026 to $1,319 million, accelerating from prior quarters. This outpaces the asset management industry average of ~8%, driven by rising AUM and fee income.
- High and Expanding Margins: Net margin reached 46.1% in Q1 2026, up from 53.7% in Q1 2025, while gross margin expanded to 82.3% from 76.0%. These margins are well above the industry average of ~20%, reflecting strong operational leverage.
- Healthy Balance Sheet: Debt-to-equity is only 0.41 and current ratio is 4.20, indicating minimal financial risk. Free cash flow of $2,315 million TTM provides ample capacity for dividends and reinvestment.
- Analyst Consensus Buy: 18 analysts rate BAM a Buy with a mean target of $56.58, implying 15.4% upside from $49.02. The high target of $69.00 suggests potential 40.7% upside if growth accelerates.
Bearish
- Elevated Valuation Multiple: Trailing PE of 34.0x is a 70% premium to the industry average of ~20x. While justified by growth, any disappointment could trigger multiple contraction, as the stock is near the high end of its historical PE range (5.6x-43.7x).
- Stock in Sustained Downtrend: BAM is down 13.6% over the past year and trades at 76.5% of its 52-week range. The 1-year relative strength vs. SPY is -34.5%, indicating persistent underperformance and weak momentum.
- High Payout Ratio Limits Reinvestment: The payout ratio is 113.4%, meaning dividends exceed earnings. This is unsustainable without continued earnings growth and could pressure the balance sheet if growth slows.
- Wide Analyst Target Spread: Target prices range from $44.00 (10.2% downside) to $69.00, reflecting high uncertainty. The low target implies potential for significant downside if AUM growth disappoints.
BAM Technical Analysis
BAM is in a sustained downtrend, with a 1-year price change of -13.6% and currently trading at 76.5% of its 52-week range ($42.20 low to $64.10 high). The stock sits at $49.02, well below the midpoint of its range, indicating bearish sentiment and potential value opportunity if fundamentals support a reversal. The 52-week low of $42.20 provides a key support level, while the high of $64.10 represents significant resistance. Short-term momentum shows a mixed picture: the 1-month change is +1.7%, while the 3-month change is +1.0%, suggesting a tentative stabilization after the longer-term decline. However, the 6-month change of -7.1% and year-to-date change of -8.3% indicate that the recent bounce is weak relative to the broader downtrend. The stock's beta of 1.259 implies 25.9% more volatility than the S&P 500, amplifying both downside risk and upside potential. The 52-week low of $42.20 serves as critical support; a break below could signal further downside, while a move above the 52-week high of $64.10 would indicate a trend reversal. The current price is 16% above the low, suggesting some buying interest, but the stock remains 23.5% below the high, highlighting the strength of overhead resistance.
Beta
1.26
1.26x market volatility
Max Drawdown
-32.2%
Largest decline past year
52-Week Range
$42-$64
Price range past year
Annual Return
-16.4%
Cumulative gain past year
| Period | BAM Return | S&P 500 |
|---|---|---|
| 1m | +2.0% | +0.1% |
| 3m | +0.5% | +5.7% |
| 6m | -6.1% | +8.5% |
| 1y | -16.4% | +20.3% |
| ytd | -7.3% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAM Fundamental Analysis
Revenue has shown steady growth, with Q1 2026 revenue of $1,319 million, up 22.1% year-over-year from $1,081 million in Q1 2025. The multi-quarter trend is positive, with revenue increasing from $1,090 million in Q2 2025 to $1,236 million in Q4 2025, indicating accelerating growth. The primary revenue drivers are management service fees ($860 million) and incentive fees ($130 million), reflecting strong AUM growth and performance. This growth trajectory supports the investment case for BAM as a beneficiary of rising asset management demand. Profitability is robust, with net income of $608 million in Q1 2026 and a net margin of 46.1%. Gross margin expanded to 82.3% in Q1 2026 from 73.2% in Q4 2025, indicating improving operational efficiency. The company is consistently profitable, with net income growing from $581 million in Q1 2025 to $608 million in Q1 2026, and margins are well above industry averages for asset managers. The balance sheet is healthy, with a debt-to-equity ratio of 0.41 and a current ratio of 4.20, indicating strong liquidity. Free cash flow for the trailing twelve months is $2,315 million, providing ample capacity for dividends and reinvestment. ROE is 27.9%, reflecting efficient capital utilization, while the low debt levels suggest minimal financial risk.
Quarterly Revenue
$1.3B
2026-03
Revenue YoY Growth
+22.1%
YoY Comparison
Gross Margin
82.3%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAM Overvalued?
Given net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 34.0x, while the forward PE is 22.5x, implying the market expects significant earnings growth. The gap between trailing and forward PE suggests a forward earnings growth rate of approximately 51%, which is optimistic but supported by the company's strong growth trajectory. Compared to the asset management industry average PE of approximately 20x, BAM trades at a 70% premium on a trailing basis. This premium is justified by BAM's superior growth (22% revenue growth vs. industry average of ~8%), higher margins (net margin 46% vs. industry ~20%), and market-leading scale. However, the premium is substantial and leaves little room for error. Historically, BAM's trailing PE has ranged from 5.6x (Q4 2022) to 43.7x (Q4 2023). The current 34.0x is near the higher end of its historical band, indicating that the market is pricing in optimistic expectations. This suggests that any disappointment in growth could lead to multiple contraction.
PE
34.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: BAM's payout ratio of 113.4% is a red flag, as dividends exceed net income, potentially requiring debt or asset sales to fund payouts if earnings dip. While the debt-to-equity ratio is low at 0.41, the reliance on continued AUM growth to sustain fee income is a key risk—any slowdown in fundraising or market depreciation could pressure revenue. The 46.1% net margin, while impressive, leaves little room for cost-cutting if revenue falters, and the high operating margin of 65.8% suggests fixed costs are significant.
Market & Competitive Risks: The stock's beta of 1.259 implies 25.9% more volatility than the market, amplifying downside in selloffs. The trailing PE of 34.0x is a 70% premium to the asset management industry average of ~20x, making it vulnerable to multiple compression if growth slows or interest rates rise. Competitive pressure from larger peers like Blackstone and KKR could limit market share gains, and the recent news of Brookfield's partnership with Bloom Energy, while positive, introduces execution risk in new ventures.
Worst-Case Scenario: A sustained market downturn could reduce AUM and fee income, triggering a re-rating of the stock. If the PE contracts to the industry average of 20x on forward earnings, the stock could fall to approximately $32 (based on forward EPS of $2.71), representing a 35% decline from the current price of $49.02. This aligns with the 52-week low of $42.20, which is 14% below current levels, but a deeper correction to $32 is possible if earnings disappoint and multiples compress further.
FAQ
The key risks are: 1) Valuation risk: trailing PE of 34.0x leaves little room for error; a re-rating to the industry average of 20x could cause a 35% decline. 2) Dividend sustainability: the payout ratio of 113.4% means dividends exceed earnings, which is unsustainable without growth. 3) Macro sensitivity: beta of 1.259 means the stock is 26% more volatile than the market, amplifying losses in downturns. 4) Competitive risk: larger peers like Blackstone and KKR could outpace BAM in fundraising. The most severe risk is a growth slowdown leading to multiple compression and a potential 35% downside to $32.
The 12-month forecast is mixed. The base case (50% probability) targets $49-57, with the stock reaching the analyst average of $56.58 if growth continues at 15-20%. The bull case (25% probability) targets $56-69, driven by accelerating AUM growth and multiple expansion. The bear case (25% probability) targets $42-49, with a potential drop to the 52-week low of $42.20 if growth disappoints. The most likely scenario is the base case, assuming BAM sustains its growth trajectory. Key assumptions include AUM growth of 10-15% and net margins above 45%.
BAM is overvalued relative to its industry but fairly valued relative to its own growth. The trailing PE of 34.0x is a 70% premium to the asset management industry average of ~20x, indicating the market is paying up for BAM's superior growth and margins. However, the forward PE of 22.5x implies expected earnings growth of ~51%, which is aggressive but supported by the company's trajectory. Historically, BAM's PE has ranged from 5.6x to 43.7x, and the current 34.0x is near the high end, suggesting the market is pricing in optimistic expectations. The stock is not cheap, but the premium may be justified if growth continues.
BAM is a good buy for long-term growth investors willing to accept near-term volatility. The stock offers 15.4% upside to the analyst average target of $56.58, supported by 22.1% revenue growth and 46.1% net margins. However, the trailing PE of 34.0x is a 70% premium to the industry, and the stock has declined 13.6% over the past year. The biggest downside risk is a 14% drop to the 52-week low of $42.20 if growth disappoints. For risk-tolerant investors, it's a buy on pullbacks; for conservative investors, waiting for a better entry near $44 may be prudent.
BAM is more suitable for long-term investment due to its growth profile and volatility. The stock's beta of 1.259 and 1-year decline of 13.6% make it risky for short-term trading. The dividend yield of 4.6% provides income for long-term holders, but the high payout ratio limits growth. With strong fundamentals and a secular growth trend in alternative assets, a minimum holding period of 3-5 years is recommended to ride out volatility and allow compounding to work. Short-term traders may find better opportunities elsewhere given the stock's weak momentum.